

Case Report

KCI, an Acelity company, is proud to collaborate with Cureus to introduce the first Negative Pressure Wound Therapy with Instillation publishing competition.
Negative Pressure Wound Therapy with Instillation (NPWTi-d) combines the benefits of NPWT with controlled delivery of topical solutions and suspensions over the wound bed. In addition to reducing edema and promoting perfusion and granulation tissue formation, the inclusion of instillation therapy assists with wound cleansing by loosening and removing soluble contaminants between dressing changes.
To encourage continued research and knowledge sharing focused on recent advances to Negative Pressure Wound Therapy with Instillation, we are seeking the following:
The winner of this competition will be determined by general acclaim of the medical community using Cureus SIQ™ crowdsourcing technology. To encourage knowledge sharing and cross-disciplinary awareness, all published materials will be indexed with PubMed Central and made accessible for open-access full article review. Related publications will also be distributed to large communities of clinicians worldwide. We encourage you to contribute!
The entry period is now closed. Competition entries appear below as they are published. Now is your chance to score and discuss these articles. Remember, prizes will be awarded to the three highest-scoring articles!
Competition entry and article submission is entirely free. All submitted work must be previously unpublished. Eligible entries include original articles, case reports and technical reports.
All articles must be submitted and formatted via the template-driven, self-publishing Cureus platform. Authors are encouraged to include supporting animations and videos within their article submissions. Reference limits vary by article type. For additional information on publishing with Cureus, please refer to our Author Guide.
Statement of Independence
Other Stipulations
Winning Article Awards
Three monetary prizes will be awarded to the published articles that receive the highest Cureus SIQ™ (Scholarly Impact Quotient™) score:
Subsequent to a formal editorial and peer review, published articles undergo SIQ scoring - Cureus’ unique crowdsourced, secondary peer-review process. In addition to measuring engagement, SIQ allows the community-at-large to rate the quality of individual articles. Reviewers assign scores from 1 to 10 on criteria including clarity and rationale, clinical importance, study design and methods, data analysis, novelty of conclusions and quality of presentation.
Aggregated community SIQ scores allow clinicians and researchers to quickly assess article quality in a manner similar to that of Amazon® and Yelp® community reviews.
Eligible articles must receive a minimum of 5 scores. (A Cureus user can assign only one score per article.) As engagement and scoring is critical to winning, authors are highly encouraged to share their published articles via social media and email.
Referral Award
Not interesting in submitting related research? Please help further medical discovery by referring this publishing program to relevant colleagues within your network. Be the first to refer the winning article author and you’ll receive $1,000 USD for your efforts.
Please click here to refer this program to colleagues.
Sunshine Act Reporting
Section 6002 of the Affordable Care Act requires applicable manufacturers of covered drugs, devices, biologicals, and medical supplies to report payments or other transfers of value made to physicians and teaching hospitals. For winning article and referral awards paid to “covered recipients,” award fees shall be supplied to KCI for subsequent Sunshine Act reporting.
We’ve assembled a world-class peer review panel to review all submitted articles. Click on a reviewer name to learn more.
Article analysis and commentary performed by the peer review panel are strictly independent of the sponsor.